bullish

Mural Oncology Plc (MURA) - Tuesday, Dec 26, 2023

255 Views26 Mar 2024 18:52
Syndicated
SUMMARY
  • MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from Alkermes
  • Despite a rough start, it is gaining attention and has a market cap of $74 million with $16/share in cash
  • Morgan Stanley projects a trading value range estimate of $32-$63/share based on potential sales from their lead pipeline candidate; company is funded with $275 million in cash until 2025

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Logo
Value Investors Club
External reports (aggregated public sources)
Value Investors Club
Equity Bottom-UpEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
  • Mural Oncology Plc (MURA) - Tuesday, Dec 26, 2023
    26 Mar 2024
x